H.R. 10150

Advancing Botanical Drug Development Act of 2026

1 cosponsor

Where it stands

Referred to the House Committee on Energy and Commerce. (Aug 27)

No roll-call votes yet.

No official summary yet.

Sec. 1. Short title

Sec. 2. Findings

Sec. 3. Period of market exclusivity for botanical drugs